Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Operating Expenses (2021 - 2026)

Cingulate's (CINGW) quarterly Operating Expenses came in at $5.4 million in Q2 2026, up 16.45% on a YoY basis from $4.6 million in Q2 2025, and down 3.07% quarter-over-quarter from $5.6 million in Q4 2025.

Analysis

Cingulate (CINGW) Operating Expenses (2021 - 2026) Analysis & Trends

Cingulate (CINGW) has reported Operating Expenses for 6 consecutive years, with $5.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Expenses rose 16.45% year-over-year to $5.4 million; the trailing twelve-month figure through Jun 2026 stood at $21.6 million (up 21.3% YoY), and the FY2025 full-year result was $19.9 million, up 27.44% from the prior year.
  • Operating Expenses fell to $5.4 million in Q2 2026 per CINGW's latest filing, from $5.6 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $6.8 million in Q4 2023 and bottomed at $2.9 million in Q1 2024.
  • Historically, Operating Expenses has averaged $4.8 million across 5 years, with a median of $4.6 million in 2025.
  • The widest YoY moves for Operating Expenses: up 276.6% in 2022, down 74.03% in 2022.
  • Over 5 years, Operating Expenses stood at $4.5 million in 2022, then jumped by 51.89% to $6.8 million in 2023, then dropped by 8.66% to $6.2 million in 2024, then fell by 10.02% to $5.6 million in 2025, then decreased by 3.07% to $5.4 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods registered $5.4 million, $5.6 million, and $6.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 644.70 Bn 623.94 Bn 17.26 Bn 10.12 Bn
2 AbbVie 441.16 Bn 434.59 Bn 12.70 Bn 10.56 Bn
3 Merck 364.92 Bn 357.78 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 266.48 Bn 258.79 Bn 11.24 Bn -6.09 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn 6.68 Bn
6 Sanofi 52.53 Bn 45.15 Bn 10.79 Bn -5.98 Bn
7 Revolution Medicines 44.20 Bn 44.20 Bn - 505.13 Mn
8 Incyte 25.27 Bn 20.74 Bn 1.57 Bn 976.14 Mn
9 United Therapeutics 21.44 Bn 18.78 Bn 683.80 Mn 452.50 Mn
10 Cingulate 100,214.03 100,214.03 - 5.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.41 Mn
Dec 31, 2025 5.59 Mn
Sep 30, 2025 6.00 Mn
Jun 30, 2025 4.65 Mn
Mar 31, 2025 3.71 Mn
Dec 31, 2024 6.21 Mn
Sep 30, 2024 3.28 Mn
Jun 30, 2024 3.21 Mn
Mar 31, 2024 2.95 Mn
Dec 31, 2023 6.80 Mn
Sep 30, 2023 5.75 Mn
Jun 30, 2023 6.36 Mn
Mar 31, 2023 3.85 Mn
Dec 31, 2022 4.48 Mn
Sep 30, 2022 3.97 Mn
Jun 30, 2022 4.05 Mn
Mar 31, 2022 5.01 Mn
Dec 31, 2021 2.65 Mn
Sep 30, 2021 15.28 Mn
Jun 30, 2021 1.42 Mn